ABBOTT LABORATORIES (ABT) Stock Fundamental Analysis

NYSE:ABT • US0028241000

112.68 USD
+1.21 (+1.09%)
At close: Feb 13, 2026
112.299 USD
-0.38 (-0.34%)
After Hours: 2/13/2026, 8:04:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to ABT. ABT was compared to 185 industry peers in the Health Care Equipment & Supplies industry. While ABT has a great profitability rating, there are some minor concerns on its financial health. ABT has a decent growth rate and is not valued too expensively. Finally ABT also has an excellent dividend rating. With these ratings, ABT could be worth investigating further for dividend investing!.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • In the past year ABT was profitable.
  • In the past year ABT had a positive cash flow from operations.
  • ABT had positive earnings in each of the past 5 years.
  • Of the past 5 years ABT 4 years had a positive operating cash flow.
ABT Yearly Net Income VS EBIT VS OCF VS FCFABT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

1.2 Ratios

  • The Return On Assets of ABT (16.60%) is better than 97.84% of its industry peers.
  • ABT has a Return On Equity of 27.43%. This is amongst the best in the industry. ABT outperforms 98.38% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 8.88%, ABT belongs to the top of the industry, outperforming 88.65% of the companies in the same industry.
Industry RankSector Rank
ROA 16.6%
ROE 27.43%
ROIC 8.88%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ABT Yearly ROA, ROE, ROICABT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

1.3 Margins

  • ABT's Profit Margin of 31.88% is amongst the best of the industry. ABT outperforms 98.92% of its industry peers.
  • ABT's Profit Margin has improved in the last couple of years.
  • ABT's Operating Margin of 18.29% is amongst the best of the industry. ABT outperforms 89.73% of its industry peers.
  • In the last couple of years the Operating Margin of ABT has grown nicely.
  • With a Gross Margin value of 56.19%, ABT perfoms like the industry average, outperforming 55.68% of the companies in the same industry.
  • ABT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 18.29%
PM (TTM) 31.88%
GM 56.19%
OM growth 3Y-0.87%
OM growth 5Y4.37%
PM growth 3Y-2.51%
PM growth 5Y2.53%
GM growth 3Y0.26%
GM growth 5Y-0.01%
ABT Yearly Profit, Operating, Gross MarginsABT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ABT is destroying value.
  • ABT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ABT Yearly Shares OutstandingABT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B
ABT Yearly Total Debt VS Total AssetsABT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

2.2 Solvency

  • ABT has an Altman-Z score of 5.34. This indicates that ABT is financially healthy and has little risk of bankruptcy at the moment.
  • With an excellent Altman-Z score value of 5.34, ABT belongs to the best of the industry, outperforming 80.54% of the companies in the same industry.
  • The Debt to FCF ratio of ABT is 1.87, which is an excellent value as it means it would take ABT, only 1.87 years of fcf income to pay off all of its debts.
  • ABT has a better Debt to FCF ratio (1.87) than 88.11% of its industry peers.
  • A Debt/Equity ratio of 0.23 indicates that ABT is not too dependend on debt financing.
  • ABT has a Debt to Equity ratio (0.23) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF 1.87
Altman-Z 5.34
ROIC/WACC0.9
WACC9.89%
ABT Yearly LT Debt VS Equity VS FCFABT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.3 Liquidity

  • ABT has a Current Ratio of 1.70. This is a normal value and indicates that ABT is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of ABT (1.70) is worse than 69.19% of its industry peers.
  • ABT has a Quick Ratio of 1.24. This is a normal value and indicates that ABT is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of ABT (1.24) is worse than 65.95% of its industry peers.
Industry RankSector Rank
Current Ratio 1.7
Quick Ratio 1.24
ABT Yearly Current Assets VS Current LiabilitesABT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • ABT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 10.28%, which is quite good.
  • The Earnings Per Share has been growing slightly by 7.13% on average over the past years.
  • The Revenue has been growing slightly by 5.67% in the past year.
  • The Revenue has been growing slightly by 5.08% on average over the past years.
EPS 1Y (TTM)10.28%
EPS 3Y-1.2%
EPS 5Y7.13%
EPS Q2Q%11.94%
Revenue 1Y (TTM)5.67%
Revenue growth 3Y0.51%
Revenue growth 5Y5.08%
Sales Q2Q%4.42%

3.2 Future

  • The Earnings Per Share is expected to grow by 10.38% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 7.06% on average over the next years.
EPS Next Y11.5%
EPS Next 2Y10.76%
EPS Next 3Y10.33%
EPS Next 5Y10.38%
Revenue Next Year7%
Revenue Next 2Y7.2%
Revenue Next 3Y7.11%
Revenue Next 5Y7.06%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ABT Yearly Revenue VS EstimatesABT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20B 40B 60B
ABT Yearly EPS VS EstimatesABT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

5

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 21.88, ABT is valued on the expensive side.
  • Compared to the rest of the industry, the Price/Earnings ratio of ABT indicates a rather cheap valuation: ABT is cheaper than 81.62% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 26.68, ABT is valued at the same level.
  • The Price/Forward Earnings ratio is 19.62, which indicates a rather expensive current valuation of ABT.
  • ABT's Price/Forward Earnings ratio is rather cheap when compared to the industry. ABT is cheaper than 81.62% of the companies in the same industry.
  • ABT is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 28.06, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 21.88
Fwd PE 19.62
ABT Price Earnings VS Forward Price EarningsABT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • 76.76% of the companies in the same industry are more expensive than ABT, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, ABT is valued cheaper than 80.54% of the companies in the same industry.
Industry RankSector Rank
P/FCF 28.33
EV/EBITDA 18.02
ABT Per share dataABT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • The decent profitability rating of ABT may justify a higher PE ratio.
PEG (NY)1.9
PEG (5Y)3.07
EPS Next 2Y10.76%
EPS Next 3Y10.33%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

7

5. Dividend

5.1 Amount

  • ABT has a Yearly Dividend Yield of 2.26%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 0.20, ABT pays a better dividend. On top of this ABT pays more dividend than 97.30% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.84, ABT pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.26%

5.2 History

  • The dividend of ABT is nicely growing with an annual growth rate of 11.40%!
  • ABT has paid a dividend for at least 10 years, which is a reliable track record.
  • ABT has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)11.4%
Div Incr Years34
Div Non Decr Years34
ABT Yearly Dividends per shareABT Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

5.3 Sustainability

  • 28.93% of the earnings are spent on dividend by ABT. This is a low number and sustainable payout ratio.
  • ABT's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP28.93%
EPS Next 2Y10.76%
EPS Next 3Y10.33%
ABT Yearly Income VS Free CF VS DividendABT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B
ABT Dividend Payout.ABT Dividend Payout, showing the Payout Ratio.ABT Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

ABBOTT LABORATORIES

NYSE:ABT (2/13/2026, 8:04:00 PM)

After market: 112.299 -0.38 (-0.34%)

112.68

+1.21 (+1.09%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)01-22
Earnings (Next)04-14
Inst Owners81.33%
Inst Owner Change-0.28%
Ins Owners0.45%
Ins Owner Change0.04%
Market Cap195.94B
Revenue(TTM)44.33B
Net Income(TTM)13.98B
Analysts80
Price Target136.02 (20.71%)
Short Float %1.15%
Short Ratio2.28
Dividend
Industry RankSector Rank
Dividend Yield 2.26%
Yearly Dividend2.21
Dividend Growth(5Y)11.4%
DP28.93%
Div Incr Years34
Div Non Decr Years34
Ex-Date01-15
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-0.82%
Min EPS beat(2)-1.06%
Max EPS beat(2)-0.58%
EPS beat(4)1
Avg EPS beat(4)-0.52%
Min EPS beat(4)-1.16%
Max EPS beat(4)0.73%
EPS beat(8)3
Avg EPS beat(8)0.07%
EPS beat(12)7
Avg EPS beat(12)1.63%
EPS beat(16)11
Avg EPS beat(16)5.69%
Revenue beat(2)0
Avg Revenue beat(2)-0.81%
Min Revenue beat(2)-1.29%
Max Revenue beat(2)-0.33%
Revenue beat(4)0
Avg Revenue beat(4)-1.08%
Min Revenue beat(4)-1.37%
Max Revenue beat(4)-0.33%
Revenue beat(8)0
Avg Revenue beat(8)-0.75%
Revenue beat(12)4
Avg Revenue beat(12)0.15%
Revenue beat(16)8
Avg Revenue beat(16)1.85%
PT rev (1m)-7.35%
PT rev (3m)-7.37%
EPS NQ rev (1m)-0.01%
EPS NQ rev (3m)-0.04%
EPS NY rev (1m)0.16%
EPS NY rev (3m)0.17%
Revenue NQ rev (1m)-0.03%
Revenue NQ rev (3m)0.03%
Revenue NY rev (1m)-0.91%
Revenue NY rev (3m)-0.63%
Valuation
Industry RankSector Rank
PE 21.88
Fwd PE 19.62
P/S 4.47
P/FCF 28.33
P/OCF 21.49
P/B 3.85
P/tB 9.16
EV/EBITDA 18.02
EPS(TTM)5.15
EY4.57%
EPS(NY)5.74
Fwd EY5.1%
FCF(TTM)3.98
FCFY3.53%
OCF(TTM)5.24
OCFY4.65%
SpS25.21
BVpS29.3
TBVpS12.3
PEG (NY)1.9
PEG (5Y)3.07
Graham Number58.27
Profitability
Industry RankSector Rank
ROA 16.6%
ROE 27.43%
ROCE 11.52%
ROIC 8.88%
ROICexc 9.99%
ROICexgc 19.14%
OM 18.29%
PM (TTM) 31.88%
GM 56.19%
FCFM 15.78%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-0.87%
OM growth 5Y4.37%
PM growth 3Y-2.51%
PM growth 5Y2.53%
GM growth 3Y0.26%
GM growth 5Y-0.01%
F-Score8
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF 1.87
Debt/EBITDA 1.04
Cap/Depr 70.33%
Cap/Sales 5.02%
Interest Coverage 250
Cash Conversion 81.77%
Profit Quality 49.49%
Current Ratio 1.7
Quick Ratio 1.24
Altman-Z 5.34
F-Score8
WACC9.89%
ROIC/WACC0.9
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)10.28%
EPS 3Y-1.2%
EPS 5Y7.13%
EPS Q2Q%11.94%
EPS Next Y11.5%
EPS Next 2Y10.76%
EPS Next 3Y10.33%
EPS Next 5Y10.38%
Revenue 1Y (TTM)5.67%
Revenue growth 3Y0.51%
Revenue growth 5Y5.08%
Sales Q2Q%4.42%
Revenue Next Year7%
Revenue Next 2Y7.2%
Revenue Next 3Y7.11%
Revenue Next 5Y7.06%
EBIT growth 1Y15.18%
EBIT growth 3Y-0.36%
EBIT growth 5Y9.67%
EBIT Next Year25.17%
EBIT Next 3Y13.91%
EBIT Next 5Y13.17%
FCF growth 1Y6.65%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y4.48%
OCF growth 3YN/A
OCF growth 5YN/A

ABBOTT LABORATORIES / ABT FAQ

What is the fundamental rating for ABT stock?

ChartMill assigns a fundamental rating of 6 / 10 to ABT.


What is the valuation status of ABBOTT LABORATORIES (ABT) stock?

ChartMill assigns a valuation rating of 5 / 10 to ABBOTT LABORATORIES (ABT). This can be considered as Fairly Valued.


What is the profitability of ABT stock?

ABBOTT LABORATORIES (ABT) has a profitability rating of 7 / 10.


What are the PE and PB ratios of ABBOTT LABORATORIES (ABT) stock?

The Price/Earnings (PE) ratio for ABBOTT LABORATORIES (ABT) is 21.88 and the Price/Book (PB) ratio is 3.85.


Can you provide the expected EPS growth for ABT stock?

The Earnings per Share (EPS) of ABBOTT LABORATORIES (ABT) is expected to grow by 11.5% in the next year.